Health Care & Life Sciences » Pharmaceuticals | Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,009
7,085
7,077
6,185
5,624
6,287
Cost of Goods Sold (COGS) incl. D&A
4,176
4,983
4,990
4,291
3,557
3,803
Gross Income
1,833
2,102
2,087
1,893
2,067
2,484
SG&A Expense
1,425
1,658
1,633
1,621
1,736
2,006
EBIT
352
381
399
-
323
463
Unusual Expense
-
-
23
2
2
3
Non Operating Income/Expense
39
2
82
41
69
6
Interest Expense
52
56
40
24
13
15
Pretax Income
359
364
503
349
411
477
Income Tax
56
51
79
58
58
73
Equity in Affiliates
58
67
34
118
120
163
Consolidated Net Income
361
379
458
409
473
568
Net Income
352
358
451
424
476
562
Net Income After Extraordinaries
352
358
451
424
476
562
Net Income Available to Common
352
358
451
424
476
562
EPS (Basic)
0.48
0.48
0.60
0.55
0.62
0.73
Basic Shares Outstanding
739
739
752
769
769
769
EPS (Diluted)
0.48
0.48
0.60
0.55
0.62
0.73
Diluted Shares Outstanding
739
739
752
769
769
769
EBITDA
441
469
474
337
400
543
Other Operating Expense
55
63
56
12
8
15
Non-Operating Interest Income
6
23
25
54
33
18
Minority Interest Expense
9
22
6
15
3
6

About Tianjin Zhongxin Pharmaceutical Group Corp.

View Profile
Address
Zhongxin Building
Tianjin Tianjin 300193
China
Employees -
Website -
Updated 07/08/2019
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.